Tuesday, October 20, 2020
9:29 AM
Reuters/Moscow
Russia's sovereign wealth fund said on Friday it had agreed to supply up to 35 million doses of the Russian experimental vaccine against Covid-19 to Uzbekistan's Laxisam, a pharmaceutical company.
The deal is one of several agreed by the Russian Direct Investment Fund (RDIF) in recent weeks to supply the vaccine, which is currently being tested in a large-scale trial in Moscow, abroad.
It has also inked supply deals with Kazakhstan, India, Mexico and two states in Brazil.
Two-week lockdown imposed in Wales
Austria introducing rule of six for indoor gatherings
UK lockdowns: Wales and Manchester head towards tougher restrictions
New restrictions as Europe surges past 250,000 virus deaths
Thousands march in Belarus despite police threat to open fire
Hungarian restaurant ‘reinvents’ the wheel
Hula-hooping girl art is Banksy’s
Landslide victory for Ardern in NZ general election
Slovakia to test whole country for coronavirus
10/19/2020 2:51:07 PM
10/19/2020 12:16:01 PM
There are no comments.